Imatinib is still recommended for frontline therapy for CML

Blood Advances 2018 / 12 Vol. 2; Iss. 24

Imatinib is still recommended for frontline therapy for CML

Hantel, Andrew, Larson, Richard A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2018018614
Date:
December, 2018
File:
PDF, 649 KB
2018
Conversion to is in progress
Conversion to is failed